Data as of Dec 10
| +0.13 / +1.62%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +157.67% increase from the last price of 8.15.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.